obstruction extrahepatic duct
a. Biliary tree obstruction-the primary cause is
cholelithiasis (gall stones), then malignancies of biliary tree or head of pancreas.
Secondary biliary cirrhosis
b. Develop secondary inflammation-then
fibrosis, hepatic scarring.
a. Inflammatory ——– disease-affects ———–
autoimmune
intrahepatic bile ducts.
medium sized intrahepatic ducts
c. Thought to be an ——— etiology.
autoimmune
a. Fibrosing cholangitis of bile ducts-develop ———–
luminal obliteration
b. Liver eventually develops ———-
biliary cirrhosis
d. Note an increase in ———- and ———— in PCS patients
chronic pancreatitis
hepatocellular carcinoma (HCC)
G. Metabolic liver disease
3. Nonalcoholic steatohepatitis (NASH). Patients develop ——–, and 10-20% progress to ———- (seen primarily in ——– patients).
hepatocyte injury
cirrhosis
obese
pulmonary emphysema
of Mallory bodies and PAS positive granules
o 3 overlapping forms:
1) hepatic steatosis,
2) EtOH hepatitis,
3) cirrhosis (only develops in a minority of patients).
A. Small Intestine-reactive, non-neoplastic conditions
2. Infectious enterocolitis e.g. Vibrio cholerae, Campylobacter jejuni-
acute, self-limited colitis “traveler’s diarrhea”.
Clinical aspects of malabsorption:
1. Osteopenia, tetany:
Defective Ca, Mg, Vitamin D and protein absorption
Clinical aspects of malabsorption:
2. Amenorrhea, impotence and infertility:
Generalized malnutrition
Clinical aspects of malabsorption:
Peripheral neuropathy, nyctalopia (↓ Vitamin A)
A. Colon polyps
a. Hyperplastic:
↑ number of cells
A. Colon polyps
b. Hamartomatous:
↑ in tissue normally at this site
B. Adenoma
B. Adenoma
• Shape:
Tubular, tubulo-villous, Villous
Adenoma
• Size:
Most important predictor of malignant change
D. TNM Classification
T: Depth of tumor invasion
D. TNM Classification
N:
Lymph nodes
D. TNM Classification
M:
Metastasis